American Oncology Network, LLC (AON), a high-growth national network of independent community oncologists, announced a new alliance with Partner Oncology in Puyallup, Washington. Partner Oncology joined AON effective August 1, 2020.
American Oncology Network, LLC (AON) is pleased to announce the opening of Georgia Oncology and Hematology Consultants. The community-based practice joined AON, effective Aug. 1, 2020. AON is an alliance of physicians and veteran healthcare leaders uniting to ensure the long-term success of community oncology.
With a mission to support the long-term viability of community oncology, the American Oncology Network, LLC (AON) has named Medical Oncologist Dr. Stephen “Fred” Divers from the Genesis Cancer Center in Arkansas as the new advisory board chair. The AON Advisory Board provides strategic guidance to its growing network of physicians and practices, currently in 13 states.
While cancers of the stomach and esophagus are rare, these cancers are usually advanced by the time they are detected. An expert medical oncologist sheds light on diagnosis, risk factors and treatment.
Targeted therapy offers a new hope for cancer patients and opens the door for the development of new treatment strategies for patients who carry certain genetic mutations in their tumors.
American Oncology Network, LLC (AON) is pleased to announce that Michigan Cancer Specialists, a leading community oncology and hematology practice serving the Metro Detroit area, has joined AON, effective July 1, 2020.
At American Oncology Network (AON), patients are our top priority. We want to provide them with the best care possible throughout what is often the most stressful and scariest time of their life – and it is our physicians, nurses and employees that make that possible. That is why we strive to keep our team happy and safe, which currently means confronting the enormous challenges brought on by the COVID-19 pandemic.
Hematology/Oncology Clinic (HOC), a partner practice of American Oncology Network, LLC (AON), will expand opportunities for patients to participate in cutting-edge cancer research, as a strategic research site for Sarah Cannon Research Institute, a global leader in offering community-based clinical trials.
American Oncology Network, LLC (AON) and Sarah Cannon Research Institute (Sarah Cannon) announced today a collaboration to expand patient access to community-based clinical research. Through the partnership, AON and Sarah Cannon will offer clinical trial options to patients across several locations within AON’s network of oncology practices.
Breast cancer is most often associated with women, which is understandable as more than 276,000 women are expected to be diagnosed in 2020. Yet, breast cancer occurs in 1 of every 83 men and carries a 5% mortality rate.
14543 Global Parkway
Suite 110
Fort Myers, FL 33913